Polaris Venture Management Co. V as of June 30, 2021
Portfolio Holdings for Polaris Venture Management Co. V
Polaris Venture Management Co. V holds 7 positions in its portfolio as reported in the June 2021 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Fate Therapeutics Common Stock (FATE) | 79.2 | $50M | 570k | 86.79 | |
| Lyra Therapeutics Common Stock | 14.2 | $8.8M | 1.1M | 8.03 | |
| x4 Pharmaceuticals Common Stock | 3.2 | $2.0M | 312k | 6.50 | |
| Atyr Pharma Common Stock | 1.0 | $637k | 131k | 4.88 | |
| Dare Bioscience Common Stock | 1.0 | $617k | 326k | 1.89 | |
| Genocea Biosciences Common Stock (GNCAQ) | 0.7 | $462k | 197k | 2.34 | |
| Pulmatrix Common Stock | 0.6 | $374k | 359k | 1.04 |
